Viatris Inc
A global healthcare company that makes and sells generic medicines, complex drugs, and iconic brand-name products like Lipitor® and Lyrica®, reaching hundreds of millions of patients across more than a hundred countries. Viatris was created in 2020 when the drugmaker Mylan merged with Upjohn, the off-patent medicines arm of Pfizer, uniting two long pharmaceutical histories. It has since streamlined by selling off its women's health, over-the-counter, and active-ingredient businesses.
Granted 1.67M
Granted 237.7K · Sold 71.4K
Granted 110.6K
Granted 24.8K
Granted 24.8K
Granted 24.8K
Granted 24.8K
Granted 24.8K
Granted 129.1K
Granted 24.8K
Granted 77.9K
Granted 24.8K
Granted 24.8K
Granted 24.8K
Granted 26.0K
Granted 26.0K
Granted 23.3K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Smith Scott AndrewChief Executive Officer, Director · 14 transactions | +336.6% | 1.37M | 1.67M | — | — |
| Campbell PaulSee Remarks · 16 transactions | +24.4% | 316.5K | 237.7K | — | 71.4K |
| Enrietti AndrewSee Remarks · 14 transactions | +75% | 227.5K | 110.6K | — | — |
| Higgins Melina EDirector · 2 transactions | +13.2% | 220.0K | 24.8K | — | — |
| Parrish Mark WDirector · 2 transactions | +18.3% | 165.2K | 24.8K | — | — |
| Kilts James MDirector · 2 transactions | +18.9% | 161.3K | 24.8K | — | — |
| Mark Richard ADirector · 2 transactions | +27% | 115.0K | 24.8K | — | — |
| Cornwell W DonDirector · 2 transactions | +39.5% | 112.0K | 24.8K | — | — |
| Le Goff CorinneChief Commercial Officer · 12 transactions | +208.1% | 108.8K | 129.1K | — | — |
| Lyons Dillon JoEllenDirector · 2 transactions | +32% | 102.5K | 24.8K | — | — |
| Mistras TheodoraChief Financial Officer · 8 transactions | +166.1% | 92.8K | 77.9K | — | — |
| Groothuis Leo FransDirector · 4 transactions | +57.2% | 63.4K | 24.8K | — | — |
| Finney Elisha WDirector · 2 transactions | +65.9% | 61.5K | 24.8K | — | — |
| Vivaldi Coelho RogerioDirector · 2 transactions | +113.2% | 45.4K | 24.8K | — | — |
| Damelio Frank ADirector · 2 transactions | — | 26.0K | 26.0K | — | — |
| Severino MichaelDirector · 2 transactions | — | 26.0K | 26.0K | — | — |
| Simmons David SDirector · 2 transactions | — | 23.5K | 23.3K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -71.4K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.